Pure Financial Advisors, LLC Astrazeneca PLC Transaction History
Pure Financial Advisors, LLC
- $6.06 Billion
- Q3 2025
A detailed history of Pure Financial Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Pure Financial Advisors, LLC holds 4,198 shares of AZN stock, worth $375,301. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,198
Previous 3,220
30.37%
Holding current value
$375,301
Previous $225,000
43.11%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,528Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...